Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Two new meta-analyses confirm once-daily Lantus efficacy and reduced risk of hypoglycaemia compared to NPH Insulin
Sanofi-aventis, 10/01/09

Sanofi–aventis announced results of a new analysis that found a significantly lower risk of nocturnal hypoglycaemia with Lantus as compared to NPH insulin. A separate post–hoc sub–analysis found a greater HbA1c and FBG reduction for elderly patients over 65 years of age taking Lantus as compared to NPH insulin.


Today in Research & Development...keeping you current

FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09

Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09

Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09

See All of Research & Development

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address